Discordant xenogeneic neonatal thymic transplantation can induce donor-specific tolerance

被引:36
作者
Khan, A
Sergio, JJ
Zhao, Y
Pearson, DA
Sachs, DH
Sykes, M
机构
[1] MASSACHUSETTS GEN HOSP,TRANSPLANTAT BIOL RES CTR,SURG SERV,BOSTON,MA 02129
[2] HARVARD UNIV,SCH MED,BOSTON,MA 02129
关键词
D O I
10.1097/00007890-199701150-00023
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The limited supply of human organs for transplantation necessitates the development of methods leading to acceptance of xenografts, To avoid the hazards of the high-dose chronic immunosuppressive pharmacotherapy which would otherwise be required for successful xenografting, it would be desirable to induce permanent tolerance to xenogeneic donors. We have recently demonstrated that xenogeneic donor-specific tolerance can be induced by transplanting fetal pig thymic and hematopoietic tissue into thymectomized, T cell-depleted, and natural killer-cell-depleted mice, or into natural killer cell-depleted nude mice. We have now extended these studies by replacing fetal tissue with neonatal pig thymic and hematopoietic tissue, and by examining the in vivo responses of reconstituted mice to pig skin grafts, Neonatal tissue was studied because it might be more practicable than fetal tissue for the purpose of transplantation to primates. BALB/c nu/nu mice transplanted with neonatal (<24-hr-old) pig thymus and spleen fragments developed circulating mouse CD4(+) cells. The pig thymus grafts were necessary for mouse T-cell development, as CD4 recovery did not occur in recipients of neonatal pig splenic tissue alone, The CD4(+) cells that developed included V beta 8.1/2(+) T cells in similar proportions as in BALB/c mice, and V beta 11(+) and V beta 5(+) CD4 T cells were deleted almost as completely as in normal BALB/c mice, This deletion was detected among CD4 single-positive graft thymocytes. In 9 of 12 evaluable animals, mixed lymphocyte responses demonstrated tolerance to donor type pig SLA antigens, with responsiveness to alloantigens and/or third-party pig xenoantigens. Furthermore, grafting of neonatal pig thymus conferred the ability to reject allogeneic mouse skin in 7 of 10 animals, In addition, 7 of 10 animals accepted paternal (donor SLA-matched) skin (median survival time [MST] > 100 days), whereas 4 of 4 animals rejected third-party SLA-mismatched pig skin (MST=40.5 days). We conclude that neonatal pig thymi transplanted to BALB/c nu/nu mice can support the development of mouse CD4(+) cells that are functional and specifically tolerant to donor-type pig antigens.
引用
收藏
页码:124 / 131
页数:8
相关论文
共 13 条
[1]   THE MHC MOLECULE I-E IS NECESSARY BUT NOT SUFFICIENT FOR THE CLONAL DELETION OF V-BETA-11-BEARING T-CELLS [J].
BILL, J ;
KANAGAWA, O ;
WOODLAND, DL ;
PALMER, E .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (04) :1405-1419
[2]  
DIALYNAS DP, 1983, J IMMUNOL, V131, P2445
[3]   LINKAGE OF MLS GENES TO ENDOGENOUS MAMMARY-TUMOR VIRUSES OF INBRED MICE [J].
FRANKEL, WN ;
RUDY, C ;
COFFIN, JM ;
HUBER, BT .
NATURE, 1991, 349 (6309) :526-528
[4]   THYMIC REQUIREMENT FOR CLONAL DELETION DURING T-CELL DEVELOPMENT [J].
FRY, AM ;
JONES, LA ;
KRUISBEEK, AM ;
MATIS, LA .
SCIENCE, 1989, 246 (4933) :1044-1046
[5]   SELF-TOLERANCE ALTERS T-CELL RECEPTOR EXPRESSION IN AN ANTIGEN-SPECIFIC MHC RESTRICTED IMMUNE-RESPONSE [J].
FRY, AM ;
MATIS, LA .
NATURE, 1988, 335 (6193) :830-832
[6]   FAILURE OF T-CELL RECEPTOR-V-BETA NEGATIVE SELECTION IN AN ATHYMIC ENVIRONMENT [J].
HODES, RJ ;
SHARROW, SO ;
SOLOMON, A .
SCIENCE, 1989, 246 (4933) :1041-1044
[7]  
IKATA K, 1992, ANNU REV IMMUNOL, V10, P759
[8]   CHARACTERIZATION OF MIXED ALLOGENEIC CHIMERAS - IMMUNOCOMPETENCE, INVITRO REACTIVITY, AND GENETIC SPECIFICITY OF TOLERANCE [J].
ILDSTAD, ST ;
WREN, SM ;
BLUESTONE, JA ;
BARBIERI, SA ;
SACHS, DH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 162 (01) :231-244
[9]   SPECIFIC TOLERANCE ACROSS A DISCORDANT XENOGENEIC TRANSPLANTATION BARRIER [J].
LEE, LA ;
GRITSCH, HA ;
SERGIO, JJ ;
ARN, JS ;
GLASER, RM ;
SABLINSKI, T ;
SACHS, DH ;
SYKES, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (23) :10864-10867
[10]  
SARMIENTO M, 1980, J IMMUNOL, V125, P2665